A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1038 | Th1007 | Leuprolide | PHWSYLLR Full view | 8 | IIa | Cancer | Eligard | Atrix Labs/QLT In | Suspension | Subcutaneous Injection | Antineoplastic Agents, Hormonal and fertility agents, estrogen antagonists | Gonadotropin-releasing hormone receptor |
| 1382 | Th1060 | Insulin, porcine | A chain: GIVEQCCTSIC Full view | 51 | Ia | Hormonal/Metabolic | vetsulin | Intervet Inc (Merck Animal Health) | Sterile injectable suspension in multidose vials containing 10 mL of 40 IU/mL porcine insulin zinc suspension | Subcutaneous Injection | Hypoglycemic Agents | Interferon alpha/beta receptor 2,Interferon alpha/beta receptor 1, Hyaluronan, Transforming growth factor beta-1 |
| 1503 | Th1105 | Insulin Aspart | A chain: GIVEQCCTSIC Full view | 51 | Ia | Hormonal/Metabolic | NovoLog Mix 50/50 | Novo Nordisk | Uniform, white, sterile suspension that contains insulin aspart | Subcutaneous injection | Hypoglycemic Agents and Antidiabetic Agents | Insulin receptor |
| 1504 | Th1105 | Insulin Aspart | A chain: GIVEQCCTSIC Full view | 51 | Ia | Hormonal/Metabolic | NovoLog Mix 70/30 | Novo Nordisk | Uniform, white, sterile suspension that contains insulin aspart 100 Units/mL. | Subcutaneous injection | Hypoglycemic Agents and Antidiabetic Agents | Insulin receptor |
| 1634 | Th1140 | Insulin, Isophane Or Nph Insulin (Neutral Protamine Hagedorn) | A chain: GIVEQCCTSIC Full view | 51 | Ia | Hormonal/Metabolic | Novolin N | Novo Nordisk | Novolin N InnoLet (nph, human insulin isophane suspension 3 ml disposable prefilled syringe) | Subcutaneous injection | Hypoglycemic Agents and Antidiabetic Agents | Insulin receptor |
| 1641 | Th1146 | Lucinactant | KLLLLKLLLLKLLLLKLLLL Full view | 21 | Ib | Genetic | Surfaxin | Discovery Laboratories, Inc. | Suspension | Intratracheal administration | Pulmonary surfactants | N.A. |
| 1662 | Th1154 | OspA lipoprotein | MKKYLLGIGLILALIACKQN Full view | 272 | IIIa | Infectious | Lymerix | SmithKline Beecham | Sterile suspension | Intramuscular Injection | Vaccines | Toll-like receptor 2 |
| 1706 | Th1169 | Beractant | NA Full view | 0 | Ia | Respiratory | Survanta | Abb Vie Inc. | Suspension | Endotracheal | NA | NA |
| 1707 | Th1169 | Beractant | NA Full view | 0 | Ia | Respiratory Disorder | Survanta | Abbvie Corporation | Suspension | Intratracheal | NA | NA |
| 1810 | Th1201 | Poractant alfa | NA Full view | 0 | Ia | Respiratory Disorder | Curosurf | Chiesi USA, Inc | Suspension | Endotracheal | Pulmonary Surfactants | |
| 1821 | Th1212 | Insulin Pork | A chain GIVEQCCTSICS Full view | 68 | Ia | Metabolic Disorders | Iletin II | Lilly | sterile suspension | Subcutaneous | Hypoglycemic Agents, Antidiabetic Agents | Insulin receptor, Insulin-like growth factor 1 receptor, Insulin-degrading enzyme, HLA class II histocompatibility antigen, DQ alpha 2 chain, HLA class II histocompatibility antigen, DQ beta 1 chain, Retinoblastoma-associated protein, Cathepsin D, Carboxypeptidase E, Neuroendocrine convertase 2, Neuroendocrine convertase 1, Protein NOV homolog, Low-density lipoprotein receptor-related protein 2, Insulin-like growth factor-binding protein 7, Synaptotagmin-like protein 4, Cytochrome P450 1A2 |
| 1840 | Th1229 | Hepatitis A Vaccine | NA Full view | 0 | IIIa | Infectious Disease | Avaxim | Sanofi Pasteur Limited | Suspension | Intramuscular | Vaccine | NA |
| 1841 | Th1229 | Hepatitis A Vaccine | NA Full view | 0 | IIIa | Infectious Disease | Havrix | Dispensing Solutions, Inc. | Suspension | Intramuscular | Vaccine | NA |